---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289496528.md"
description: "On Thursday, several healthcare stocks experienced significant intraday volatility. Gainers included Gelteq (+150.7%), Propanc Biopharma (+134.07%), and Adial Pharmaceuticals (+43.98%). Conversely, major losers were Atossa Therapeutics (-42.2%), Purple Biotech (-34.46%), and Aditxt (-27.03%). These movements reflect sharp price fluctuations in the sector during regular trading hours."
datetime: "2026-06-11T17:05:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289496528.md)
  - [en](https://longbridge.com/en/news/289496528.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289496528.md)
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Gelteq** (NASDAQ:GELS) stock increased by 150.7% to $1.29 during Thursday's regular session. The company's market cap stands at $5.5 million.
-   **Propanc Biopharma** (NASDAQ:PPCB) stock increased by 134.07% to $3.16. The market value of their outstanding shares is at $3.0 million.
-   **Adial Pharmaceuticals** (NASDAQ:ADIL) stock increased by 43.98% to $3.11. The market value of their outstanding shares is at $4.6 million.
-   **Theriva Biologics** (AMEX:TOVX) shares moved upwards by 37.33% to $0.33. The company's market cap stands at $11.1 million.
-   **Indaptus Therapeutics** (NASDAQ:INDP) shares rose 31.42% to $3.22. The market value of their outstanding shares is at $277.4 million.
-   **Rafael Holdings** (NYSE:RFL) shares increased by 19.1% to $2.12. The company's market cap stands at $92.5 million. As per the press release, Q3 earnings came out today.

### Losers

-   **Atossa Therapeutics** (NASDAQ:ATOS) shares decreased by 42.2% to $2.54 during Thursday's regular session. The company's market cap stands at $37.8 million.
-   **Purple Biotech** (NASDAQ:PPBT) shares decreased by 34.46% to $1.94. The market value of their outstanding shares is at $2.7 million.
-   **Aditxt** (NASDAQ:ADTX) shares decreased by 27.03% to $0.01.
-   **Humacyte** (NASDAQ:HUMA) shares fell 24.26% to $1.01. The company's market cap stands at $297.5 million.
-   **BGM Group** (NASDAQ:BGM) stock declined by 19.21% to $0.34. The company's market cap stands at $85.2 million.
-   **Valion Bio** (NASDAQ:VBIO) stock decreased by 17.91% to $0.65. The market value of their outstanding shares is at $2.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [GELS.US](https://longbridge.com/en/quote/GELS.US.md)
- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)
- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)
- [PPBT.US](https://longbridge.com/en/quote/PPBT.US.md)
- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)
- [ATOS.US](https://longbridge.com/en/quote/ATOS.US.md)
- [TOVX.US](https://longbridge.com/en/quote/TOVX.US.md)
- [INDP.US](https://longbridge.com/en/quote/INDP.US.md)
- [RFL.US](https://longbridge.com/en/quote/RFL.US.md)
- [HUMA.US](https://longbridge.com/en/quote/HUMA.US.md)
- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)
- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)
- [PPCBD.US](https://longbridge.com/en/quote/PPCBD.US.md)
- [HUMAW.US](https://longbridge.com/en/quote/HUMAW.US.md)

## Related News & Research

- [Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million | ADTX Stock News](https://longbridge.com/en/news/289184727.md)
- [Adial Pharmaceuticals Completes Azora Merger, Shifts Strategic Focus](https://longbridge.com/en/news/289496601.md)
- [Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing | ADIL Stock News](https://longbridge.com/en/news/289489523.md)
- [VERAXA Biotech (NASDAQ: VRXA) Is ‘One to Watch’](https://longbridge.com/en/news/289628511.md)
- [Adial Pharmaceuticals Acquires Azora and Raises $26.8M PIPE, With More on Milestones](https://longbridge.com/en/news/289495450.md)